CVR: 36428023
PULMOPHARMA ApS is a Danish company of the type Anpartsselskab based in Ebeltoft, founded in 2014. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Dan Mønster Nielsen. The company's owners include PETER BANG HOLDING ApS, LARS NYENSTAD ApS and BENDIX-HOLDING ApS. In 2025, the company reported a gross profit of DKK -49,353 and a net result of DKK -49,353 compared with DKK -20,499 the year before. Equity amounted to DKK 11,436,934.
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er udvikling af et nyt medicinsk præparat.
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | -49 t. | -49 t. | 13.6 mio. | 11.4 mio. | 0 | |
| 2024 | -20 t. | -20 t. | 9.3 mio. | 7.4 mio. | 0 | |
| 2023 | -47 t. | -47 t. | 8.9 mio. | 7.4 mio. | 0 | |
| 2022 | -56 t. | -63 t. | 5 mio. | 3.4 mio. | 0 | |
| 2021 | -80 t. | -93 t. | 4 mio. | 3.5 mio. | 0 | |
| 2020 | -1 t. | -19 t. | 80 t. | -395 t. | 1 | |
| 2019 | -9 t. | -26 t. | 80 t. | -376 t. | - | |
| 2018 | -292 t. | -224 t. | 75 t. | -350 t. | - | |
| 2017 | -120 t. | -123 t. | 30 t. | -126 t. | - | |
| 2016 | 0 | 0 | 80 | -3 t. | - |
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationCompared to 1.052 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
PULMOPHARMA ApS has published its annual report for 2025. Gross profit came to DKK -49,353, and the net result was DKK -49,353.
PULMOPHARMA ApS has published its annual report for 2024. Gross profit came to DKK -20,499, and the net result was DKK -20,499.
As of March 27, 2025, LARS NYENSTAD ApS is registered as an owner of PULMOPHARMA ApS with an ownership share of 20%.
As of March 27, 2025, BENDIX-HOLDING ApS is registered as an owner of PULMOPHARMA ApS with an ownership share of 20%.
As of March 27, 2025, LouMar ApS is registered as an owner of PULMOPHARMA ApS with an ownership share of 20%.
PULMOPHARMA ApS has published its annual report for 2023. Gross profit came to DKK -47,300, and the net result was DKK -47,300.
PULMOPHARMA ApS has published its annual report for 2022. Gross profit came to DKK -56,496, and the net result was DKK -62,830.
As of April 11, 2023, PETER BANG HOLDING ApS is registered as an owner of PULMOPHARMA ApS with an ownership share of 25%.
PULMOPHARMA ApS has published its annual report for 2021. Gross profit came to DKK -80,380, and the net result was DKK -93,103.
PULMOPHARMA ApS has published its annual report for 2020. Gross profit came to DKK -1,060, and the net result was DKK -18,958.
As of May 28, 2021, Per Bendix Jeppesen has joined the board of directors of PULMOPHARMA ApS.
As of May 28, 2021, Dan Mønster Nielsen has joined the board of directors of PULMOPHARMA ApS.
As of May 28, 2021, Peter Frithjof Bang has joined the board of directors of PULMOPHARMA ApS.
As of May 28, 2021, Torben Ballegaard Sørensen has joined the board of directors of PULMOPHARMA ApS.
PULMOPHARMA ApS has published its annual report for 2019. Gross profit came to DKK -8,735, and the net result was DKK -25,905.
PULMOPHARMA ApS has published its annual report for 2018. Gross profit came to DKK -292,381, and the net result was DKK -223,907.
PULMOPHARMA ApS has published its annual report for 2017. Gross profit came to DKK -120,467, and the net result was DKK -123,491.
As of January 4, 2018, Per Bendix Jeppesen has stepped down as director of PULMOPHARMA ApS.
As of January 4, 2018, Torben Ballegaard Sørensen has stepped down as director of PULMOPHARMA ApS.
PULMOPHARMA ApS has published its annual report for 2016. Gross profit came to DKK 0, and the net result was DKK 0.
PULMOPHARMA ApS has published its interim report for the period November 1, 2014 – December 31, 2015.
As of November 1, 2014, Per Bendix Jeppesen is registered as director of PULMOPHARMA ApS.
As of November 1, 2014, Dan Mønster Nielsen is registered as director of PULMOPHARMA ApS.
As of November 1, 2014, Torben Ballegaard Sørensen is registered as director of PULMOPHARMA ApS.
PULMOPHARMA ApS was founded on November 1, 2014.
Companies in the same industry and area
CVR 32294715
CVR 32879454
CVR 40769374
CVR 38301284
CVR 25514386
companydata.dk